A new survey finds that homeopathic medicines are primarily used by a small segment of the U.S. population for common, self-limited conditions such as the common cold or back pain. The report published in the American Journal ...
Feb 18, 2016
0
11
No one worries about vaccine supply—until there's a shortage. New research from Duke University's Fuqua School of Business studied the market tensions that can keep manufacturers out of the business and the price points ...
Feb 10, 2016
0
20
Treatments to regenerate skin from burns are lengthy; however, Mexican researchers have developed a biodegradable membrane that transfers skin cells (keratinocytes) to burn wounds, when placed on the wound. The method reduces ...
Apr 2, 2015
0
8
GNC Holdings Inc. said Monday that it has reached a deal with New York Attorney General Eric Schneiderman over its Herbal Plus products.
Mar 30, 2015
0
3
Scientists at the University of Nebraska-Lincoln College of Engineering's Biological Process Development Facility have successfully produced a drug compound with potential to block HIV transmission in women.
Jul 2, 2014
0
0
(HealthDay)—A new rule that aims to ensure the safety of infant formula has been finalized by the U.S. Food and Drug Administration.
Jun 9, 2014
0
0
India's third-biggest drugs company Sun Pharma announced Monday a $3.2-billion deal to buy larger domestic rival Ranbaxy from Daiichi Sankyo, ending the Japanese company's costly run as owner.
Apr 7, 2014
0
0
India's biggest drugmaker by sales, Ranbaxy Laboratories, has assured shareholders it is taking "stringent steps" to resolve a US ban on imports of medicines made at its newly renovated showcase plant.
Sep 21, 2013
0
0
Shares of Novo Nordisk tumbled Monday after the Danish drugmaker said U.S. regulators need a new study before they can finish their review of two diabetes treatments, a development that could delay approval for several years.
Feb 11, 2013
0
0
